Results 101 to 110 of about 25,335 (131)

Artificial intelligence to predict treatment response in rheumatoid arthritis and spondyloarthritis: a scoping review. [PDF]

Rheumatol Int
Benavent D, Carmona L, García Llorente JF, Montoro M, Ramirez S, Otón T, Loza E, Gómez-Centeno A.   +7 more
europepmc   +1 more source

Expert Clinical Management of Inflammatory Immune-Related Arthritis in Patients with Cancer Receiving Immune Checkpoint Inhibitors. [PDF]

J Immunother Precis Oncol
Bruera S, Riveiro-Barciela M, Meara A, Suarez-Almazor ME.   +3 more
europepmc   +1 more source

Associated diseases and their effects on disease course in patients with chronic non-bacterial osteomyelitis: retrospective experience from a single center. [PDF]

Clin Rheumatol
Öksüz Aydın B, Aydın F, Taş Ö, Bahçeci O, Özçakar ZB.   +4 more
europepmc   +1 more source

Impact of Disease-Modifying Antirheumatic Drugs on Cognitive Function in Older Adults with Rheumatoid Arthritis. [PDF]

Drugs Aging
Fazel SD, Carollo M, Tap L, Spini A, Trifirò G, Mattace-Raso FUS.   +5 more
europepmc   +1 more source

Clinical Response to Adalimumab Therapy and Its Determinants in Patients With Radiographic Axial Spondyloarthritis: A Prospective Real-World Study in Taiwan. [PDF]

Int J Rheum Dis
Liu FC, Lu CH, Kuo CF, Liao HT, Lee SS, Su KY, Sung WY, Tsai WC, Chen HH, Chen HA, Wei JC, Tseng JC, Weng MY, Chen HC, Hsieh SC.   +14 more
europepmc   +1 more source

MiR-146/TNF-α/IL-6/osteocalcin crosstalk in anti-rheumatic potential of Galleria mellonella hemolymph from computational molecular modeling to in-vivo validation. [PDF]

J Comput Aided Mol Des
Ahmed SM, Ali E, Ali AR, Mohamed MA, Abdelhafez HM, Mashaal A.   +5 more
europepmc   +1 more source

Impact of seropositivity and disease-modifying antirheumatic drugs on pulmonary tuberculosis risk in rheumatoid arthritis. [PDF]

ERJ Open Res
Choi H, Eun Y, Han K, Jung JH, Jung W, Kim H, Shin DW, Lee H.   +7 more
europepmc   +1 more source

Long-Standing Untreated or Inadequately Treated Seropositive Rheumatoid Arthritis in the Golden Age of Disease-Modifying Antirheumatic Drugs. [PDF]

Cureus
Arcilla CK, Kaeley GS, Thway M.
europepmc   +1 more source

Biological Disease-Modifying Antirheumatic Drugs Decrease Uric Acid Levels in the Sera of Patients with Psoriatic Arthritis. [PDF]

Curr Issues Mol Biol
Perković D, Petrić M, Maleš M, Erceg Maleš I, Radić M.   +4 more
europepmc   +1 more source

Hydroxychloroquine as a Promising Therapy for Systemic IgG4-Related Disease: A Case Report. [PDF]

Am J Case Rep
Fijn R, Janssens N, Bodar E, Nagtegaal MM, Karim F.   +4 more
europepmc   +1 more source